Another week - another interview from Vitalia!

VITALIA INTERVIEW SERIES - EPISODE #3: Mark Hamalainen, Co-founder of the Longevity Biotech Fellowship!

FULL INTERVIEW HERE: https://youtu.be/uI738CJpyEQ

In a world where science meets the promise of extended life, Mark Hamelainen, co-founder of the Longevity Biotech Fellowship, shares his profound insights on tackling one of humanity’s greatest challenges—aging.

In the interview, Mark highlights the current shortcomings in funding and cultural focus surrounding aging research, revealing the meager portion of National budgets allocated to this vital area. He challenges conventional approaches that prioritize treatment over prevention, and advocates for a paradigm shift in how society views aging. The discussion delves into the promise of new technologies, particularly the role of artificial intelligence in redefining the future of biotech.

SUBSCRIBE TO EISODOS MULTIMODAL HERE: https://www.youtube.com/@Eisodos

and Here:

Another week - another interview from Vitalia!

VITALIA INTERVIEW SERIES - EPISODE #3: Mark Hamalainen, Co-founder of the Longevity Biotech Fellowship!

FULL INTERVIEW HERE: https://youtu.be/uI738CJpyEQ

In a world where science meets the promise of extended life, Mark Hamelainen, co-founder of the Longevity Biotech Fellowship, shares his profound insights on tackling one of humanity’s greatest challenges—aging.

In the interview, Mark highlights the current shortcomings in funding and cultural focus surrounding aging research, revealing the meager portion of National budgets allocated to this vital area. He challenges conventional approaches that prioritize treatment over prevention, and advocates for a paradigm shift in how society views aging. The discussion delves into the promise of new technologies, particularly the role of artificial intelligence in redefining the future of biotech.

SUBSCRIBE TO EISODOS MULTIMODAL HERE: https://www.youtube.com/@Eisodos

and Here: https://paragraph.xyz/@eisodos.eth